Drawing for EXIMMIUM

USPTO serial 79404774

EXIMMIUM

Reviewed by CopyMark Law Group

Reg. 8097692Status 700Registered
Filing date
Status date
Registration date
Jan 13, 2026
Examiner
BLAZICH, JOAN MICHELE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EXIMMIUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ryan D. Artis

Ryan D. Artis Riverside Law LLP175 Strafford Ave.Suite 100Wayne, PA 19087

Goods and services

ClassDescriptionStatusFirst use
001Chemical substances, materials and preparations, namely, chemicals for industrial purposes; chemical compositions and materials, namely, chemicals for use in science; chemical components, namely, chemicals for producing a radio-labelled monoclonal antibody for industrial or scientific use; tagged antibodies for scientific purposes for laboratory use; monoclonal antibodies for scientific use; tagged antibodies for scientific use; immunological antibodies for scientific purposes, other than for medical use; monoclonal antibodies for scientific purposes for diagnostic use, other than medical use; antibodies for scientific purposes, other than for medical or veterinary use; diagnostic preparations for scientific purposes; clinical diagnostics, namely, diagnostic reagents for scientific use other than for medical or veterinary use; diagnostic reagents for in-vitro use for scientific use, other than medical use; diagnostic reagents, other than for medical use in kit form, namely, diagnostic reagent kits for scientific use comprised of reagents for scientific use and test tubesACTIVE—
005Medical and veterinary preparations, namely, pharmaceutical and biological preparations for the treatment of cancer and infectious disease; Pharmaceuticals and natural remedies in the nature of pharmaceutical and biological preparations for the treatment of cancer and infectious disease; biotechnological preparations for the treatment of cancer and infectious disease for medical use; antibodies for medical purposes; diagnostic agents for medical use; diagnostic preparations and materials, namely, diagnostic preparations for medical purposes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical purposes; anti-cancer drugs; Pharmaceutical compounds for treating cancer; pharmaceutical preparations and substances for use in oncology; clinical diagnostic reagents for medical useACTIVE—
042Science and technology services, namely, scientific research and development; natural science services, namely, scientific research; medical and pharmacological research services; information on the subject of scientific research in the field of biochemistry and biotechnology; research relating to biotechnology; biotechnology product testing; research and development in the field of biotechnology; research and development in the pharmaceutical and biotechnology fields; research and development services in the field of antibody technology; research and development services in the field of antibodies; scientific research laboratory services relating to the production of monoclonal antibodies; research and development in the field of diagnostic preparationsACTIVE—
044Human healthcare services; animal healthcare services; medical services; medical and healthcare services; human hygiene and beauty care; advisory services relating to medical services; medical services in the field of oncology; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical diagnostic services.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 18, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 17, 2026FIMPFINAL DISPOSITION PROCESSED—
Apr 13, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 5, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Feb 18, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 18, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 13, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 13, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 25, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 25, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 19, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 24, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 23, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Oct 23, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 23, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 23, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 3, 2025DOCKASSIGNED TO EXAMINER—
May 12, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 12, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 12, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 30, 2024DOCKASSIGNED TO EXAMINER—
Nov 30, 2024RFNTREFUSAL PROCESSED BY IB—
Nov 13, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 13, 2024RFRRREFUSAL PROCESSED BY MPU—
Nov 7, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 6, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2024DOCKASSIGNED TO EXAMINER—
Sep 20, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 20, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 19, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance